FDA Inspection
Actavis Laboratories UT, Inc.Actavis Laboratories UT, Inc. – FDA Inspection, Aug 20, 2021
Record Details
This FDA Inspection record concerns Actavis Laboratories UT, Inc., with an inspection on August 20, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 20, 2021
- Product Type
- Drugs
View Company Profile
ID · f9b7701a-aaf6-4b31-af9a-83201c751965
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1149636
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.122(d)Labels and labeling stored separately
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Actavis Laboratories UT, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2025 | VAI | Denver District Office | Drug Quality Assurance |
| March 19, 2024 | OAI | Drug Quality Assurance | |
| August 2, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 25, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 19, 2017 | Not classified | Denver District Office |
Other documents for Actavis Laboratories UT, Inc.
- FDA Inspection 1282698 - 2025-09-19
- FDA Inspection 1230375 - 2024-03-19
- FDA Inspection 1065736 - 2018-08-02
- FDA Inspection 1035181 - 2017-10-25
- FDA Inspection 1012979 - 2017-05-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.